Karl Egerer1, Eugen Feist, Gerd-Rüdiger Burmester. 1. Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité-Universitätsmedizin Berlin, Germany. karl.egerer@charite.de
Abstract
BACKGROUND: This article provides an overview of modern serological diagnostic testing for rheumatoid arthritis (RA) involving the detection of antibodies against citrullinated peptides/proteins (ACPA). Recommendations are also given for differential diagnosis and sequential testing in rheumatoid arthritis, with a view towards improving early diagnosis, so that irreparable joint damage can be avoided. METHODS: Selective literature research, with consideration of the authors' own publications. RESULTS: Two different, adequately evaluated testing systems, involving the detection of anti-CCP antibodies and of anti-MCV antibodies, are now commercially available and enable routine, relatively highly specific diagnostic testing for RA. Two point-of-care tests (POCT) for the early diagnosis of RA constitute the latest development in serologic diagnostic testing. CONCLUSIONS: The two ACPA assays now on the market are equally useful for the diagnosis of rheumatoid arthritis. The correlation between RA disease activity and stratification with ACPA has only been demonstrated to date through the detection of anti-MCV antibodies.
BACKGROUND: This article provides an overview of modern serological diagnostic testing for rheumatoid arthritis (RA) involving the detection of antibodies against citrullinated peptides/proteins (ACPA). Recommendations are also given for differential diagnosis and sequential testing in rheumatoid arthritis, with a view towards improving early diagnosis, so that irreparable joint damage can be avoided. METHODS: Selective literature research, with consideration of the authors' own publications. RESULTS: Two different, adequately evaluated testing systems, involving the detection of anti-CCP antibodies and of anti-MCV antibodies, are now commercially available and enable routine, relatively highly specific diagnostic testing for RA. Two point-of-care tests (POCT) for the early diagnosis of RA constitute the latest development in serologic diagnostic testing. CONCLUSIONS: The two ACPA assays now on the market are equally useful for the diagnosis of rheumatoid arthritis. The correlation between RA disease activity and stratification with ACPA has only been demonstrated to date through the detection of anti-MCV antibodies.
Entities:
Keywords:
antibody screening; autoimmune disease; early detection of disease; laboratory diagnosis; rheumatoid arthritis
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij Journal: J Clin Invest Date: 1998-01-01 Impact factor: 14.808
Authors: Erik R Vossenaar; Normand Després; Elvy Lapointe; Annemarie van der Heijden; Maximillian Lora; Tatsuo Senshu; Walther J van Venrooij; Henri A Ménard Journal: Arthritis Res Ther Date: 2004-02-05 Impact factor: 5.156
Authors: Bin Yang; Jun Long Zhang; Yun Ying Shi; Dong Dong Li; Jie Chen; Zhuo Chun Huang; Bei Cai; Xing Bo Song; Li Xin Li; Bin Wu Ying; Lan Lan Wang Journal: Mol Biol Rep Date: 2010-12-22 Impact factor: 2.316
Authors: Li Li; David J Ruau; Chirag J Patel; Susan C Weber; Rong Chen; Nicholas P Tatonetti; Joel T Dudley; Atul J Butte Journal: Sci Transl Med Date: 2014-04-30 Impact factor: 17.956
Authors: Howaida E Mansour; Khaled M Metwaly; Iman A Hassan; Hebat-Allah A Elshamy; Moataz M S Elbeblawy Journal: Clin Med Insights Arthritis Musculoskelet Disord Date: 2010-05-24